Q2 2020 Holdings
Filed 2020-08-14 | 80 holdings | $732.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $233.1M | 1,034,868 | 31.8% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $204.8M | 3,069,164 | 28.0% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $94.0M | 3,356,958 | 12.8% |
| Cryoport Inc(CYRX) | COM PAR $0.001 | 229050307 | $55.0M | 1,817,663 | 7.5% |
| Biogen Inc(BIIB) | COM | 09062X103 | $43.4M | 162,300 | 5.9% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $31.5M | 897,355 | 4.3% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $26.0M | 2,000,000 | 3.5% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $24.3M | 3,514,100 | 3.3% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $15.9M | 1,425,896 | 2.2% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $433.3K | 12,629,737 | 0.1% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $376.2K | 24,944,695 | 0.1% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $297.3K | 4,978,941 | 0.0% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $258.7K | 5,525,870 | 0.0% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $229.5K | 3,144,000 | 0.0% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $188.2K | 2,619,080 | 0.0% |
| Principia Biopharma Inc(PRNB) | COM | 74257L108 | $162.2K | 2,712,388 | 0.0% |
| Momenta Pharmaceuticals Inc(MNTA) | COM | 60877T100 | $156.5K | 4,705,308 | 0.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $136.3K | 8,485,605 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $123.7K | 3,489,900 | 0.0% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $110.7K | 3,410,657 | 0.0% |
| 1Life Healthcare Inc | COM | 68269G107 | $109.3K | 3,010,684 | 0.0% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $99.7K | 6,843,370 | 0.0% |
| Cigna Corp New(CI) | COM | 125523100 | $91.2K | 486,100 | 0.0% |
| Aprea Therapeutics Inc | COM | 03836J102 | $88.0K | 2,268,718 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $82.4K | 2,236,766 | 0.0% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $79.8K | 1,661,205 | 0.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $77.1K | 3,104,193 | 0.0% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $74.0K | 2,386,174 | 0.0% |
| Genmark Diagnostics Inc(GNMK) | COM | 372309104 | $72.1K | 4,903,400 | 0.0% |
| Neoleukin Therapeutics Inc | COM | 64049K104 | $67.1K | 4,041,211 | 0.0% |
| Hill ROM Hldgs Inc(HRC) | COM | 431475102 | $64.2K | 585,000 | 0.0% |
| Sanofi(SNY) | SPONSORED ADR | 80105N105 | $62.6K | 1,225,500 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $59.6K | 2,502,306 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $59.5K | 497,764 | 0.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $58.4K | 1,409,745 | 0.0% |
| Tricida Inc(1T7) | COM | 89610F101 | $58.2K | 2,119,000 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $56.2K | 1,247,135 | 0.0% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $55.2K | 12,006,979 | 0.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $52.4K | 2,875,889 | 0.0% |
| PPD Inc | COM | 69355F102 | $51.8K | 1,933,473 | 0.0% |
| Amedisys Inc(AMED) | COM | 023436108 | $44.9K | 226,165 | 0.0% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $44.9K | 5,062,100 | 0.0% |
| Axonics Modulation Technolog(AXNX*) | COM | 05465P101 | $41.9K | 1,192,100 | 0.0% |
| Merck & Co. Inc(MRK) | COM | 58933Y105 | $40.5K | 524,300 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $39.4K | 97,300 | 0.0% |
| Novartis AG(NVSN) | SPONSORED ADR | 66987V109 | $38.4K | 439,800 | 0.0% |
| ICU MED Inc(ICUI) | COM | 44930G107 | $37.1K | 201,400 | 0.0% |
| Genmab A/S(GMAB) | SPONSORED ADS | 372303206 | $35.8K | 1,057,393 | 0.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $30.6K | 103,900 | 0.0% |
| Catalent Inc(CTLTEUR) | COM | 148806102 | $30.3K | 413,100 | 0.0% |